Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

1 result found.

Example of search result explained

Aranesp

Exceptional medication
  • Active ingredient(s):
    darbepoetine alfa
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Syringe 100 mcg/0.5 mL DIN : 2391775
    • Syringe 10 mcg/0.4 mL DIN : 2392313
    • Syringe 130 mcg/0.65 mL DIN : 2391783
    • Syringe 150 mcg/0.3 mL DIN : 2391791
    • Syringe 200 mcg/0.4 mL DIN : 2391805
    • Syringe 20 mcg/0.5 mL DIN : 2392321
    • Syringe 300 mcg/0.6 mL DIN : 2391821
    • Syringe 30 mcg/0.3 mL DIN : 2392348
    • Syringe 40 mcg/0.4 mL DIN : 2391740
    • Syringe 500 mcg/1.0 mL DIN : 2392364
    • Syringe 50 mcg/0.5 mL DIN : 2391759
    • Syringe 60 mcg/0.3 mL DIN : 2392356
    • Syringe 80 mcg/0.4 mL DIN : 2391767
Page 1 of 1

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.